Current Investors
Meet the current Optinose® investors.
Avista Capital Partners
Avista Capital Partners is a leading private equity firm with offices in New York, Houston, and London. Founded in 2005, Avista’s strategy is to make controlling or influential minority investments in growth-oriented energy, healthcare, media, industrial and consumer businesses. Through its team of seasoned investment professionals and industry experts, Avista seeks to partner with exceptional management teams to invest in and add value to well-positioned businesses.
Visit the Avista Capital Partners Website
Entrepreneurs Fund LLP
The Entrepreneurs Fund provides early stage and growth financing alongside active support to entrepreneurial teams internationally in a broad range of technologies including life sciences. Entrepreneurs Fund is a member of COFRA Holding, one of the world’s largest family companies and, with a 170-year history, one of the longest standing. Although Entrepreneurs Fund may be a new member of this well-established family business, they share the sense of belonging and loyalty that lie at the heart of its values. This is evident both in professional ethics as much as their corporate giving. In assessing investment opportunities and talent, Entrepreneurs Fund looks for people who can combine the highest levels of creativity and boldness with a commitment to this moral high ground.
Visit the Entrepreneurs Fund LLP Website
Fidelity Management and Research Company
Fidelity Management & Research Company (FMR Co.) acts as the investment advisor to Fidelity’s family of mutual funds. FMR Co. has three fund divisions: Equity, High-Income and Fixed-Income. Securities are managed, researched, bought and sold for the funds by a staff of portfolio managers, analysts and traders.
Visit the Fidelity Management and Research Company Website
WFD Ventures LLC
WFD Ventures LLC provides equity financing and industry expertise to medical device and healthcare technology companies. The principals of WFD have extensive experience commercializing medical technologies and seek partnerships with entrepreneurs, doctors and scientists to improve medical outcomes and maximize the financial potentials of their innovations.